Impact of visceral fat on gene expression profile in peripheral blood cells in obese Japanese subjects

Cardiovascular Diabetology

Volumn 15, Issue 1, 2016, Pages

  Obata, Yoshinari ^a   Maeda, Norikazu ^a   Yamada, Yuya ^b   Yamamoto, Koji ^b   Nakamura, Seiji ^c   Yamaoka, Masaya ^a   Tanaka, Yoshimitsu ^a   Masuda, Shigeki ^a   Nagao, Hirofumi ^a   Fukuda, Shiro ^a   Fujishima, Yuya ^a   Kita, Shunbun ^a   Nishizawa, Hitoshi ^a   Funahashi, Tohru ^a   Matsubara, Ken ichi ^c   Matsuzawa, Yuji ^b   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SUMITOMO HOSPITAL   (Japan)

^c DNA CHIP RESEARCH INC   (Japan)

Author keywords

Adiponectin; Diabetes; Fat distribution; Gene expression; KLF; Metabolic syndrome; Microarray; Obesity; Subcutaneous fat; Visceral fat

Indexed keywords

GLUCOSE; LIPID; MESSENGER RNA; SIRTUIN 1; GENETIC MARKER; RNA;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOMETABOLIC RISK; CIRCADIAN RHYTHM; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIET THERAPY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE ONTOLOGY; GLUCOSE METABOLISM; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INTRAABDOMINAL FAT; JAPANESE (PEOPLE); LIPID METABOLISM; MALE; METABOLIC SYNDROME X; MICROARRAY ANALYSIS; OBESITY; OXIDATIVE STRESS; PREVALENCE; SUBCUTANEOUS FAT; TURBIDIMETRY; UPREGULATION; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGY; BLOOD; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; DNA MICROARRAY; ETHNOLOGY; GENE EXPRESSION REGULATION; GENETIC DATABASE; GENETIC MARKER; GENETICS; JAPAN; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; X-RAY COMPUTED TOMOGRAPHY;

ADIPOSITY; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC MARKERS; HUMANS; INTRA-ABDOMINAL FAT; JAPAN; MALE; MIDDLE AGED; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA; SUBCUTANEOUS FAT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84999749841     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-016-0479-1     Document Type: Article

References (27)

1. Matsuzawa Y. Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med. 2006;3:35-42.
2. Okauchi Y, Kishida K, Funahashi T, Noguchi M, Morita S, Ogawa T, et al. 4-year follow-up of cardiovascular events and changes in visceral fat accumulation after health promotion program in the Amagasaki visceral fat study. Atherosclerosis. 2010;212:698-700.
3. Hiuge-Shimizu A, Kishida K, Funahashi T, Ishizaka Y, Oka R, Okada M, et al. Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study). Ann Med. 2012;44:82-92.
4. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2004;24:29-33.
5. Matsuzawa Y, Funahashi T, Nakamura T. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J Atheroscler Thromb. 2011;18:629-39.
6. Hotamisligil GS, Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol. 2008;8:923-34.
7. Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012;489:242-9.
8. Yamaoka M, Maeda N, Nakamura S, Kashine S, Nakagawa Y, Hiuge-Shimizu A, et al. A pilot investigation of visceral fat adiposity and gene expression profile in peripheral blood cells. PLoS ONE. 2012;7:e47377.
9. Yamaoka M, Maeda N, Nakamura S, Mori T, Inoue K, Matsuda K, et al. Gene expression levels of S100 protein family in blood cells are associated with insulin resistance and inflammation. Biochem Biophys Res Commun. 2013;433:450-5.
10. Lee H, Chu SH, Park JY, Park HK, Im JA, Lee JW. Visceral adiposity is associated with SIRT1 expression in peripheral blood mononuclear cells: a pilot study. Endocr J. 2013;60:1269-73.
11. Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J. 2002;66:987-92.
12. Yoshizumi T, Nakamura T, Yamane M, Islam AH, Menju M, Yamasaki K, et al. Abdominal fat: standardized technique for measurement at CT. Radiology. 1999;211:283-6.
13. Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus, Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig. 2010;1:212-28.
14. Japanese Society of Nephrology. Evidence-based practice guideline for the treatment of CKD. Clin Exp Nephrol. 2009;13:537-66.
15. Tokunaga K, Matsuzawa Y, Ishikawa K, Tarui S. A novel technique for the determination of body fat by computed tomography. Int J Obes. 1983;7(5):437-45.
16. Matsuzawa Y, Shimomura I, Nakamura T, Keno Y, Tokunaga K. Pathophysiology and pathogenesis of visceral fat obesity. Ann N Y Acad Sci. 1995;748:399-406.
17. Smith U, Hammersten J, Björntorp P, Kral JG. Regional differences and effect of weight reduction on human fat cell metabolism. Eur J Clin Invest. 1979;9:327-32.
18. Mittelman SD, Van Citters GW, Kirkman EL, Bergman RN. Extreme insulin resistance of the central adipose depot in vivo. Diabetes. 2002;51:755-61.
19. Maeda N, Funahashi T, Shimomura I. Metabolic impact of adipose and hepatic glycerol channels aquaporin 7 and aquaporin 9. Nat Clin Pract Endocrinol Metab. 2008;4:627-34.
20. Hirata A, Maeda N, Nakatsuji H, Hiuge-Shimizu A, Okada T, Funahashi T, et al. Contribution of glucocorticoid-mineralocorticoid receptor pathway on the obesity-related adipocyte dysfunction. Biochem Biophys Res Commun. 2012;419:182-7.
21. Badman MK, Flier JS. The gut and energy balance: visceral allies in the obesity wars. Science. 2005;307:1909-14.
22. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115:1111-9.
23. Subramaniam M, Hawse JR, Rajamannan NM, Ingle JN, Spelsberg TC. Functional role of KLF10 in multiple disease processes. BioFactors. 2010;36:8-18.
24. Venuprasad K, Huang H, Harada Y, Elly C, Subramaniam M, Spelsberg T, et al. The E3 ubiquitin ligase Itch regulates expression of transcription factor Foxp3 and airway inflammation by enhancing the function of transcription factor TIEG1. Nat Immunol. 2008;9:245-53.
25. Cao Z, Wara AK, Icli B, Sun X, Packard RR, Esen F, et al. Kruppel-like factor KLF10 targets transforming growth factor-beta1 to regulate CD4(+)CD25(-) T cells and T regulatory cells. J Biol Chem. 2009;284:24914-24.
26. Guillaumond F, Gréchez-Cassiau A, Subramaniam M, Brangolo S, Peteri-Brünback B, Staels B, et al. Kruppel-like factor KLF10 is a link between the circadian clock and metabolism in liver. Mol Cell Biol. 2010;30:3059-70.
27. Gutierrez-Aguilar R, Benmezroua Y, Balkau B, Marre M, Helbecque N, Charpentier G, et al. Minor contribution of SMAD7 and KLF10 variants to genetic susceptibility of type 2 diabetes. Diabetes Metab. 2007;33:372-8.